BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,537,163 | -16.4% | 105,496 | +11.0% | 0.00% | 0.0% |
| Q2 2023 | $3,036,032 | +112637.9% | 95,084 | +8.1% | 0.00% | 0.0% |
| Q1 2023 | $2,693 | -20.4% | 87,948 | +1.6% | 0.00% | -40.0% |
| Q4 2022 | $3,385 | -99.9% | 86,540 | +1.9% | 0.01% | -16.7% |
| Q3 2022 | $4,047,000 | +37.2% | 84,957 | +11.5% | 0.01% | +50.0% |
| Q2 2022 | $2,949,000 | -5.1% | 76,194 | +40.6% | 0.00% | 0.0% |
| Q1 2022 | $3,106,000 | -24.8% | 54,202 | +4.6% | 0.00% | -20.0% |
| Q4 2021 | $4,129,000 | -8.6% | 51,813 | -0.2% | 0.01% | -16.7% |
| Q3 2021 | $4,519,000 | -27.9% | 51,941 | +6.6% | 0.01% | -25.0% |
| Q2 2021 | $6,272,000 | +79.3% | 48,731 | +11.5% | 0.01% | +60.0% |
| Q1 2021 | $3,498,000 | -7.3% | 43,701 | -5.5% | 0.01% | 0.0% |
| Q4 2020 | $3,775,000 | +313.9% | 46,237 | +24.9% | 0.01% | +400.0% |
| Q3 2020 | $912,000 | +122.4% | 37,033 | +152.8% | 0.00% | 0.0% |
| Q2 2020 | $410,000 | +95.2% | 14,647 | +25.3% | 0.00% | – |
| Q1 2020 | $210,000 | – | 11,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |